Dosing Study of Remifentanil for Smooth Removal of the Laryngeal Mask Airway (LMA)

• Status: Completed
• Trial end date: 2014-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators attempted to determine the optimal effect-site concentration of remifentanil for smooth removal of the LMA from propofol anesthesia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ajou University School of Medicine
• Treatments: Propofol; Remifentanil

Criteria

Inclusion Criteria:

• ASA I-II patients undergoing general anesthesia for short elective surgery (<1 hr)

Exclusion Criteria:

• G-E reflux

• obesity (BMI>30)

• anticipated difficult airway